FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a delivery system including a nucleus and a membrane enclosing said nucleus where said nucleus and membrane consist substantially of an elastomer composition, and said nucleus contains at least one therapeutically active agent. The delivery system is characterised by the fact that the membrane contains at least one control agent specified in a group consisting of cyclodextrins and modified cyclodextrins.
EFFECT: invention provides constant release rate of the therapeutically active agent over a long period of time.
5 cl, 3 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR DELIVERING MEDICINAL AGENTS OF ANTI-PROGESTINE ACTIVITY | 2000 |
|
RU2228170C2 |
DRUG DELIVERY SYSTEM | 2002 |
|
RU2302883C2 |
OTORHINOLOGICAL DELIVERING DEVICE | 2004 |
|
RU2334525C2 |
METHOD FOR PREPARING A DRUG DELIVERY DEVICE AND A DRUG DELIVERY DEVICE MADE BY SAID METHOD | 2016 |
|
RU2732822C2 |
METHOD FOR MODIFIED RELEASE OF THERAPEUTICALLY ACTIVE AGENT FROM ELASTOMERIC MATRIX | 2018 |
|
RU2780242C2 |
DEVICE FOR DELIVERING MEDICAMENT, MAINLY FOR DELIVERING ANDROGENS | 1999 |
|
RU2226388C2 |
DEVICE FOR DELIVERING MEDICAMENT, MAINLY FOR DELIVERING PROGESTINS AND ESTROGENS | 1999 |
|
RU2226387C2 |
INTRAVAGINAL DRUG DELIVERY SYSTEM AND METHOD FOR MAKING SAME | 2009 |
|
RU2541812C2 |
NOVEL MEMBRANE OR MATRIX FOR ADJUSTABLE PENETRATION OF MEDICINAL DRUGS | 1999 |
|
RU2231531C2 |
USE OF TOCOPHEROL | 2008 |
|
RU2461584C2 |
Authors
Dates
2011-02-27—Published
2005-07-05—Filed